Summit, AstraZeneca in talks over $15 billion partnership deal, Bloomberg News reports
(Reuters) -Summit Therapeutics and AstraZeneca are discussing a partnership deal worth as much as $15 billion, Bloomberg News reported on ...
Read moreDetails(Reuters) -Summit Therapeutics and AstraZeneca are discussing a partnership deal worth as much as $15 billion, Bloomberg News reported on ...
Read moreDetails
